Simultaneous estimation of chlorthalidone and efonidipine hydrochloride in bulk and tablet dosage form
Abstract
Chlorthalidone and efonidipine hydrochloride are anti-hypertensive agents with different mechanisms of action. These drugs are generally used as monotherapy; however, recent study suggests their use in combination reduces the mortality rate. Based on this evidence, Zuventus Healthcare limited developed a combination dosage (Efnocar Ct) which has been recently approved for its use. Hence, a new, sensitive, precise and robust method was developed and validated to determine the purity of the compounds in bulk as well as tablet dosage forms. The HPLC analysis was achieved on Zobrax 150 column using acetonitrile and ammonium formate (60:40% v/v) as the mobile phase and the detection was achieved at a λ max of 248nm. The linearity was achieved between the concentration range of 3µg/ml – 18µm/ml for chlorthalidone and 10µg/ml – 60µg/ml concentration range for efonidipine hydrochloride. The % recovery for chlorthalidone was 100.03% and that for efonidipine was 100.24%, indicating the method to be accurate. The LOD and LOQ values for chlorthalidone was 0.01µg/ml and 0.02µg/ml and for efonidipine it was 0.26µg/ml and 0.88µg/ml. This indicates the sensitivity of the method. Robustness studies have shown no significant variations and degradation studies have shown acceptable results. The results of the proposed method for linearity, accuracy, sensitivity and robustness were within the acceptable limits.
Keywords
Hypertension combination dose chlorthalidone efonidipine hydrochloride method development validation
References
- [1] World Health Organization. Guideline for the pharmacological treatment of hypertension in adults: summary. https://www.who.int/publications/i/item/9789240050969 (accessed April 14, 2023).
- [2] Deaths due to high blood pressure, 2019. https://ourworldindata.org/grapher/deaths-due-to-high-blood-pressure?country=CHN~RUS~IND~USA~BRA~ARG (accessed April 24, 2023).
- [3] Rimoldi SF, Messerli FH, Chavez P, Stefanini GG, Scherrer U. Efficacy and safety of calcium channel blocker/diuretics combination therapy in hypertensive patients: A meta-analysis. J Clin Hypertens. 2015;17(3):193–9. https://doi.org/10.1111/jch.12462.
- [4] Central Drugs Standard Control Organization. Recommendations of the SEC (Cardiovascular & Renal). 2020.https://www.cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadCommitteeFiles/73rdSECCardiovascular & Renal6fe20.pdf (acessed April 24, 2023).
- [5] Shahin MH, Johnson JA. Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response. Curr Opin Pharmacol. 2016; 27 :31–37. https://doi.org/10.1016/j.coph.2016.01.005.
- [6] Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, Tu W. Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med. 2021;385(27):2507-2519. https://doi.org/10.1056/nejmoa2110730.
- [7] Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010;56(3):463–470. https://doi.org/10.1161/HYPERTENSIONAHA.110.154476
- [8] Rapoport RM, Soleimani M. Mechanism of thiazide diuretic arterial pressure reduction: The search continues. Front Pharmacol. 2019; 10: 815. https://doi.org/10.3389/fphar.2019.00815.
- [9] De la Espriella R, Cobo M, Núñez J. Thiazides in chronic kidney disease: “back to the future.” Clin Kidney J. 2023;16(1):1–4. https://doi.org/10.1093/ckj/sfac228.
- [10] Oh IY, Seo MK, Lee HY, Kim SG, Kim KS, Kim WH, Hyon MS, Han KR, Lim SJ, Kim JH. Beneficial effect of efonidipine, an L- and T-type dual calcium channel blocker, on heart rate and blood pressure in patients with mild-to-moderate essential hypertension. Korean Circ J. 2010;40(10):514–519. https://doi.org/10.4070/kcj.2010.40.10.514.
- [11] Jariwala P, Jadhav K. The safety and efficacy of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in indian patients with mild-to-moderate essential hypertension. Eur Heart J. 2022;43. https://doi.org/10.1093/eurheartj/ehab849.143.
- [12] Wang N, Ye L, Ku S, Zhao BQ, Yu JX. Spectroscopic studies on the interaction of efonidipine with bovine serum albumin. Braz J Med Biol Res. 2008;41(7):589-595. https://doi.org/10.1590/S0100-879X2008000700007
- [13] Kumar GS, Ramya V, Mondal S, Kumar SP. Development and validation of RP-HPLC method for simultaneous estimation of Atenolol and Chlorthalidone in pharmaceutical formulation. Int Res J Pharm. 2012; 3(10): 215-219.
- [14] Liu M, Zhao H, Tong Y, Zhang D, Wang X, Zhang L, Han J, Liu H. Determination of efonidipine in human plasma by LC-MS/MS for pharmacokinetic applications. J Pharm Biomed Anal. 2015; 103: 1–6. https://doi.org/10.1016/j.jpba.2014.11.001.
- [15] Aneesh TP, Radhakrishnan R, Aravind PM, Sasidharan A, Choyal M. RP-HPLC method for simultaneous determination of Losartan and Chlorthalidone in pharmaceutical dosage form. Int Res J Pharm. 2015;6(7):453–457. https://doi.org/10.7897/2230-8407.06793.
- [16] Dangre P, Sawale V, Meshram S, Gunde M. Development and validation of RP-HPLC method for the simultaneous estimation of eprosartan mesylate and chlorthalidone in tablet dosage form. Int J PharmTech Res. 2015;8(2):163–168.
- [17] Aishwarya J. Method development and validation for the estimation of Telmisartan and Chlorthalidone in bulk and pharmaceutical dosage form by HPTLC method. Res J Pharm Technol. 2015;8(4):376–381. https://doi.org/10.5958/0974-360X.2015.00063.3.
- [18] Liu M, Deng M, Zhang D, Wang X, Ma J, Zhao H, Zhang L, Tong Y, Liu H. A chiral LC-MS/MS method for the stereospecific determination of efonidipine in human plasma. J Pharm Biomed Anal. 2016;122(15):35–41. https://doi.org/10.1016/j.jpba.2016.01.039.
- [19] Kumar A, Shoni SK, Dahiya M, Kumar R, Yadav AK, Kumar V, Chaudhary H. Development and validation of liquid chromatography (RP-HPLC) methodology for estimation of Efonidipine HCl Ethanolate (EFD). Pharm Anal Acta. 2017;8(5). https://doi.org/10.4172/2153-2435.1000547
- [20] Abdullah NS, Hassan MA, Hassan RO. Spectrophotometric determination of chlorthalidone in pharmaceutical formulations using different order derivative methods. Arab J Chem. 2017;10(2):3426–3433. https://doi.org/10.1016/j.arabjc.2014.02.002.
- [21] Rathod RH, Patil AS, Shirkhedkar AA. Novel NP and RP-HPTLC in praxis for simultaneous estimation of Chlorthalidone and Cilnidipine in bulk and pharmaceutical formulation. Anal Chem Lett. 2018;8(6):862–871. https://doi.org/10.1080/22297928.2018.1527252.
- [22] Kharat C, Shirsat VA, Kodgule YM, Kodgule M. A Validated RP-HPLC stability method for the estimation of Chlorthalidone and its process-related impurities in an API and tablet formulation. Int J Anal Chem. 2020: 1-11. https://doi.org/10.1155/2020/3593805.
- [23] Rajput AS, Jha DK, Gurram S, Shah DS, Amin PD. RP-HPLC method development and validation for the quantification of Efonidipine hydrochloride in HME processed solid dispersions. Futur J Pharm Sci. 2020;6(70):1-9. https://doi.org/10.1186/s43094-020-00094-2.
- [24] Pandya CP, Rajput SJ. Forced degradation study of efonidipine HCl ethanolate, characterization of degradation products by LC-Q-TOF-MS and NMR. J Appl Pharm Sci. 2020;10(4):75–99. https://doi.org/10.7324/japs.2020.104012.
- [25] Chaudhari SR, Shirkhedkar AA. Application of Plackett-Burman and central composite designs for screening and optimization of factor influencing the chromatographic conditions of HPTLC method for quantification of efonidipine hydrochloride. J Anal Sci Technol. 2020;11(48). https://doi.org/10.1186/s40543-020-00246-2
- [26] Prajapati P, Patel S, Mishra A. Simultaneous estimation of azilsartan medoxomil and chlorthalidone by chromatography method using design of experiment and quality risk management based quality by design approach. J Planar Chromatogr - Mod TLC. 2020;33:631–646. https://doi.org/10.1007/s00764-020-00067-4.
- [27] Vyas AJ, Gol DA, Usdad RG, Patel AI, Patel AB, Patel NK, Chudasama A. HPTLC-densitometric method for simultaneous estimation of Olmesartan medoxomil and Chlorthalidone in tablet dosage form. Anal Chem Lett. 2020;10(4):498–506. https://doi.org/101080/2229792820201814859.
- [28] Prajapati P, Patel M, Shah S. A robust high-performance thin-layer chromatography method for the simultaneous estimation of chlorthalidone and metoprolol succinate using quality risk assessment and design of experiments-based enhanced analytical quality by design approach. J Planar Chromatogr - Mod TLC. 2021;34(3):229–242. https://doi.org/10.1007/s00764-021-00107-7.
- [29] Solanki D, Patel D, Meshram D. Development and validation of UV Spectrophotometric method for simultaneous estimation of Efonidipine hydrochloride ethanolate and Chlorthalidone in their synthetic mixture. Drug Anal Res. 2022;6(1):27–34. https://doi.org/10.22456/2527-2616.125170.
- [30] Wang X, Sacramento CQ, Jockusch S, Chaves OA, Tao C, Fintelman-Rodrigues N, Chien M, Temerozo JR, Li X, Kumar S, Xie W, Patel DJ, Meyer C, Garzia A, Tuschl T, Bozza PT, Russo JJ, Souza TML, Ju J. Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture. Commun Biol. 2022;5(1):154. https://doi.org/10.1038/s42003-022-03101-9.
- [31] Patel GH, Adeshra SD, Meshram DB. RP-HPLC method development and validation for simultaneous estimation of efonidipine hydrochloride ethanolate and telmisartan in their synthetic mixture. Int J Pharm Drug Anal. 2021;9(3):190–195. https://doi.org/10.47957/ijpda.v9i3.480.
- [32] Rahi S, Rana A. Role of ICH guidelines in registration of pharmaceutical products. Int J Drug Regul Aff. 2019;7(4):14–27. https://doi.org/10.22270/ijdra.v7i4.365.
Details
| Primary Language | English |
|---|---|
| Subjects | Pharmaceutical Analytical Chemistry, Pharmaceutical Delivery Technologies, Pharmacology and Pharmaceutical Sciences (Other) |
| Journal Section | Articles |
| Authors | |
| Publication Date | June 28, 2025 |
| Published in Issue | Year 2024 Volume: 28 Issue: 5 |